Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy.
about
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the futureBlocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy.Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy.Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergyA B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help.Grass pollen immunotherapy: where are we now.Molecular aspects of allergens in atopic dermatitisDevelopments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy.Dimerisation increases the immunogenicity of recombinant Parj1/Parj2 allergens.Next generation immunotherapy for tree pollen allergies.Immunotherapy with B cell epitopes ameliorates inflammatory responses in Balb/c mice.Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches.
P2860
Q26768511-DB41EE10-040C-4B75-90BD-50D9D737CA07Q33710566-322E2EF7-B665-4E4D-AA3C-7B4007F40023Q35558343-11ED4494-2C7E-49F9-B512-0103DC079AC2Q37309704-F351C00A-73AF-470C-94D6-533DFE1F5725Q37625474-F4F943E0-45A9-49C0-90DE-16D30407DCB9Q38773340-D227862F-2423-44AC-BE9E-A009425390C3Q39378515-A8037192-AE5B-4454-B8B2-970802B076EBQ40940984-65DDD12E-4A06-4EC3-B966-BF3F55DC7429Q45062704-44E6E0EB-D795-4D1E-99D6-0296EFC28C50Q47884083-9CE453EE-7BC5-4BBF-9113-38BA32D29FD4Q51702685-EDDDA1D7-954E-4F05-BCBC-A75EB1F1C8E2Q55436442-67532A11-6CD2-4928-8AEC-C9C43C005FBA
P2860
Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@ast
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@en
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@nl
type
label
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@ast
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@en
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@nl
prefLabel
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@ast
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@en
Prophylactic and therapeutic v ...... odel for birch pollen allergy.
@nl
P2093
P2860
P356
P1476
Prophylactic and therapeutic v ...... model for birch pollen allergy
@en
P2093
P2860
P304
P356
10.1111/CEA.12216
P577
2014-02-01T00:00:00Z